What is Bulkamid®?
Approved by the FDA, Bulkamid is a urethral bulking agent for the treatment of stress urinary incontinence in women. Bulkamid is a soft hydrogel, consisting of 97.5% water and 2.5% polyacrylamide.
Approved by the FDA, Bulkamid is a urethral bulking agent for the treatment of stress urinary incontinence in women. Bulkamid is a soft hydrogel, consisting of 97.5% water and 2.5% polyacrylamide.
Bulkamid provides additional volume to the urethra and acts as a scaffold for cells to grow through helping to provide long lasting relief of stress urinary incontinence symptoms.
Bulkamid aims to restore the natural closing pressure of the urethra preventing urine from leaking out unintentionally during normal daily activities (e.g. when you cough, laugh, walk or exercise).
Urethral bulking is a non-mesh, minimally invasive procedure that takes around 10 – 15 minutes and is usually done in your physician’s office with a local anesthetic. In most cases patients can get back to their normal activities within a day.
The majority of women treated with Bulkamid report dryness or improvement in their symptoms, with many seeing that improvement as soon as they leave the doctor’s office.
If relief from your symptoms is not sufficient following treatment with Bulkamid, an additional insertion can be given to help achieve satisfactory results.
In the Bulkamid clinical study, women were asked how effective they felt their treatment was 12 months after their initial insertion. Over three quarters of women reported that their incontinence was either “dry, much improved or improved” and approximately half of women reported zero stress urinary incontinence episodes.